Loading...
 
 Warning
  • User not in any of the required groups for GroupSelector field

107

Items
Selected Document Category:Published Document
Source:Nanotechnology Characterization Laboratory
Anticipated Publication Year:
Publication Year:2009
Acronym:NCL
Identifier:ITA-1
Document Title:Analysis of Hemolytic Properties of Nanoparticles
url:http://ncl.cancer.gov/NCL_Method_ITA-1.pdf
Scope:

The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated.
Hemolysis (destruction of red blood cells) in vivo can lead to anemia, jaundice and other
pathological conditions.

Keywords:in vivo, hemolytic potential, nanoparticles
Type of Document:
Issues Areas:
Primary Category:
Additional Categories
Goal or Need:
Intended Stakeholders:
Is it Being Implemented:
Submitter's Name:Admin
Submitter's e-mail:[email protected]
Submitter's Company:ANSI
Additional Comments:
Contact for Additional Info:http://ncl.cancer.gov/working_assay-cascade_download.asp
Selected Document Category:Published Document
Source:Nanotechnology Characterization Laboratory
Anticipated Publication Year:
Publication Year:2009
Acronym:NCL
Identifier:ITA-1
Document Title:Analysis of Hemolytic Properties of Nanoparticles
url:http://ncl.cancer.gov/NCL_Method_ITA-1.pdf
Scope:

The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated.
Hemolysis (destruction of red blood cells) in vivo can lead to anemia, jaundice and other
pathological conditions.

Keywords:in vivo, hemolytic potential, nanoparticles
Type of Document:
Issues Areas:
Primary Category:
Additional Categories
Goal or Need:
Intended Stakeholders:
Is it Being Implemented:
Submitter's Name:Admin
Submitter's e-mail:[email protected]
Submitter's Company:ANSI
Additional Comments:
Contact for Additional Info:http://ncl.cancer.gov/working_assay-cascade_download.asp



::::